1. Home
  2. RYTM vs ABCB Comparison

RYTM vs ABCB Comparison

Compare RYTM & ABCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • ABCB
  • Stock Information
  • Founded
  • RYTM 2008
  • ABCB 1971
  • Country
  • RYTM United States
  • ABCB United States
  • Employees
  • RYTM 283
  • ABCB N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • ABCB Major Banks
  • Sector
  • RYTM Health Care
  • ABCB Finance
  • Exchange
  • RYTM Nasdaq
  • ABCB Nasdaq
  • Market Cap
  • RYTM 6.9B
  • ABCB 5.0B
  • IPO Year
  • RYTM 2017
  • ABCB N/A
  • Fundamental
  • Price
  • RYTM $102.12
  • ABCB $74.11
  • Analyst Decision
  • RYTM Strong Buy
  • ABCB Buy
  • Analyst Count
  • RYTM 13
  • ABCB 6
  • Target Price
  • RYTM $101.92
  • ABCB $70.67
  • AVG Volume (30 Days)
  • RYTM 550.8K
  • ABCB 371.0K
  • Earning Date
  • RYTM 11-04-2025
  • ABCB 10-23-2025
  • Dividend Yield
  • RYTM N/A
  • ABCB 1.07%
  • EPS Growth
  • RYTM N/A
  • ABCB 25.98
  • EPS
  • RYTM N/A
  • ABCB 5.67
  • Revenue
  • RYTM $156,287,000.00
  • ABCB $1,116,353,000.00
  • Revenue This Year
  • RYTM $44.69
  • ABCB $12.89
  • Revenue Next Year
  • RYTM $63.53
  • ABCB $5.40
  • P/E Ratio
  • RYTM N/A
  • ABCB $13.13
  • Revenue Growth
  • RYTM 53.55
  • ABCB 9.90
  • 52 Week Low
  • RYTM $45.91
  • ABCB $48.27
  • 52 Week High
  • RYTM $106.52
  • ABCB $75.46
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 60.62
  • ABCB 65.83
  • Support Level
  • RYTM $101.45
  • ABCB $71.97
  • Resistance Level
  • RYTM $106.52
  • ABCB $74.38
  • Average True Range (ATR)
  • RYTM 3.12
  • ABCB 1.36
  • MACD
  • RYTM -0.43
  • ABCB 0.14
  • Stochastic Oscillator
  • RYTM 65.84
  • ABCB 79.36

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

Share on Social Networks: